[Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003523:Cycloserine / Q000627:therapeutic use; D004654:Empyema, Tuberculous / Q000188:drug therapy*; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007539:Isonicotinic Acids / Q000627:therapeutic use; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008171:Lung Diseases / Q000188:drug therapy*; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D014391:Tuberculosis, Miliary / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007539:Isonicotinic Acids; D009025:Morpholines; D011719:Pyrazines; D004977:Ethambutol; D003523:Cycloserine; D012293:Rifampin
Comportamento di alcuni indici biologici di funzionalità epatica e renale in corso di terapia con dietilamide della rifamicina B (rifamide) somministrata per infusione venosa.